4 news items
DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis
DRRX
21 May 24
associated with stress responses, cell death and survival, and lipid biosynthesis. This may ultimately lead to improved cell survival, reduced inflammation
DURECT Corporation Reports First Quarter 2024 Financial Results and Business Update
DRRX
13 May 24
methylation, which subsequently modulates expression of genes that are involved in cell signaling pathways associated with stress responses, cell death
DURECT Corporation Announces Late-Breaking Oral Presentation at the EASL Congress 2024 to Discuss AHFIRM Phase 2b Data in Alcohol-Associated Hepatitis
DRRX
30 Apr 24
of genes that are involved in cell signaling pathways associated with stress responses, cell death and survival, and lipid biosynthesis. This may
DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
DRRX
27 Mar 24
in cell signaling pathways associated with stress responses, cell death and survival, and lipid biosynthesis. This may ultimately lead to improved
- Prev
- 1
- Next